Fluidigm agrees to buy VC-backed DVS Sciences
Fluidigm Corp. has agreed to acquire DVS Sciences for a consideration of approximately $207.5 million in cash and stock. Piper Jaffray & Co. advised Fluidigm on the transaction while Jefferies advised DVS. Headquartered in Sunnyvale, Calif., DVS Sciences is a maker of bioanalytical solutions. Its backers included 5AM Ventures, Mohr Davidow Ventures and Pfizer Venture Investments.
29 January 2014•6 mins read
